Skip to main content
. 2021 Oct 18;65(11):e01208-21. doi: 10.1128/AAC.01208-21

FIG 3.

FIG 3

Study design. Subjects in SAD cohort 4, part 2, were dosed in the fed state; all others were fasting. BID, twice daily; MAD, multiple ascending dose; PK, pharmacokinetic; SAD, single ascending dose; SMG, safety monitoring group; QD, once daily.